Department of Medical Affairs, MCM Klosterfrau Vertriebsgesellschaft mbH, Germany
Research
Multicentre, Prospective, Non-Interventional Study With Neo-Angin® Benzydamine, 3 Mg Lozenges For Treatment Of Acute Sore Throat, Lemon Flavour, To Evaluate The Tolerability, Acceptance And Course Of Symptoms In The Treatment Of Acute Sore Throat In Adult Patients
Author(s): Nadja Schughart
Objective: To evaluate the tolerability, acceptance and course of symptoms in the treatment of acute sore throat with neo-angin® benzydamine, 3 mg lozenges for treatment of acute sore throat, lemon flavour, (neo-angin® BLF) in adult patients in routine clinical practice in Germany.
Rationale and background: Neo-angin® BLF is indicated for the symptomatic local treatment of acute sore throat in adults and children over 6 years of age. The active ingredient is benzydamine hydrochloride (3 mg/lozenge). An important safety issue in self-medication is the usage according to the designated indication and dosage. Prospective observational studies provide real world evidence of safety and effectiveness of marketed drugs and contribute to the knowledge of the drug use in self-medication.
.. View More»
